Filing Details

Accession Number:
0001223203-10-000137
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-05-21 13:00:00
Reporting Period:
2010-05-19
Filing Date:
2010-05-21
Accepted Time:
2010-05-21 16:38:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885725 Boston Scientific Corp BSX Surgical & Medical Instruments & Apparatus (3841) 042695240
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
901458 M Peter Nicholas C/O Boston Scientific Corporation
One Boston Scientific Place
Natick MA 01760-1537
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-05-19 25,000 $6.64 8,931,021 No 4 S Indirect by Limited partnership
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect by Limited partnership
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Forward Sale Contract Obligation to Sell Acquisiton 2010-05-19 237,240 $0.00 237,240 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
237,240 2012-05-18 2012-05-18 No 4 J Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 9,212,125 Direct
Common Stock 2,413,088 Indirect By Trust 2
Footnotes
  1. Sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
  2. The weighted average sales price is reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $6.69 to $6.59. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
  3. Shares held by a trust of which the reporting persons spouse and brother are trustees and the reporting persons spouse and children are beneficiaries.
  4. On March 1, 2010, the reporting person entered into a Rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. Under the contract reported on this form, the reporting person will deliver to the bank up to 237,240 shares of the Issuer's common stock depending on market prices at maturity on May 18, 2012. If the market price per share at maturity is equal to or less than the floor price of $6.6278 per share, the reporting person will deliver 237,240 shares to the bank. If the market price per share at maturity is greater than the floor price, the reporting person will deliver a fewer number of shares. In exchange, the bank is obligated to pay $1,100,665.49 to the reporting person two business days after the date of the contract. At the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock.
  5. The reporting person pledged 237,240 shares of the Issuers common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge.